Open AccessDouble-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients
Author(s) -
Hui Huang,
Hua Ping Dai,
Jian Kang,
Bao Yuan Chen,
Tie Ying Sun,
Zhigang Xu,
Hui Huang,
Hui Huang,
Hui Huang,
Hui Huang,
Hui Huang,
Hui Huang,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Hua Ping Dai,
Jian Kang,
Jian Kang,
Jian Kang,
Jian Kang,
Jian Kang,
Jian Kang,
Jian Kang,
Jian Kang,
Jian Kang,
Jian Kang,
Jian Kang,
Jian Kang,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Bao Yuan Chen,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Tie Ying Sun,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu,
Zhigang Xu
Publication year - 2015
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000001600
Subject(s) - pirfenidone , medicine , idiopathic pulmonary fibrosis , placebo , gastroenterology , clinical endpoint , vital capacity , pulmonary function testing , adverse effect , randomized controlled trial , surgery , lung , diffusing capacity , pathology , lung function , alternative medicine